Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.2.0.727
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Income Statement [Abstract]        
Revenues        
Costs and expenses:        
General and administrative costs, including $6,250 and $62,809 to related parties for the three months ended June 30, 2015 and 2014, respectively, and $87,401 and $449,687 for the six months ended June 30, 2015 and 2014, respectively $ 213,665 $ 181,557 $ 460,308 $ 734,566
Research and development costs, including $155,078 and $95,008 to related parties for the three months ended June 30, 2015 and 2014, respectively, and $508,116 and $180,478 for the six months ended June 30, 2015 and 2014, respectively 287,021 335,723 792,535 498,493
Total costs and expenses 500,686 517,280 1,252,843 1,233,059
Loss from operations (500,686) (517,280) (1,252,843) (1,233,059)
Interest income $ 35 28 46 29
Fair value of warrant extensions   $ (224,074) (34,016) (302,691)
Fair value of warrant discount     (171,757) (134,420)
Net loss $ (500,651) $ (741,326) $ (1,458,570) $ (1,670,141)
Net loss per common share - Basic and diluted $ (0.01) $ (0.02) $ (0.03) $ (0.04)
Weighted average common shares outstanding - Basic and diluted 46,709,990 45,018,262 46,107,616 43,310,169